Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103819372B details continuous pipeline synthesis for high purity DDS. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel anticancer intermediate synthesis via patent CN106397433B. High yield route offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112321660B details a streamlined acylation route for dibutyryl cAMP. Enhances purity >99% and reduces solvent usage for scalable API intermediate manufacturing.
Discover the novel CN112175003B process for Tenofovir Phenyl Ester. Eliminate TMSBr usage and hydration issues for cost-effective API manufacturing.
Patent CN117069663A reveals a mild high-yield synthesis for Ribociclib intermediates. Achieve significant cost reduction and supply chain reliability in API manufacturing.
Patent CN115521289A details a copper-catalyzed route avoiding precious metals, offering cost-effective manufacturing for pharmaceutical intermediates.
Novel resolution method for optically pure ephedrine using L-(-)-dibenzoyltartaric acid. High yield, recoverable agent, scalable industrial process.
Patent CN1512996A reveals a novel crystalline salt method for high-purity Cefdinir. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel preparation method for anti-drug-resistance anti-tumor EGFR inhibitor intermediates. Reduces cost, improves purity, and ensures scalable supply chain continuity.
Patent CN107382725B reveals a continuous flow method for L-menthyl glycolate, offering high purity and yield for Lamivudine synthesis while reducing industrial waste.
Patent CN113493411A reveals a high-yield milrinone synthesis route offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Discover a breakthrough Milrinone synthesis route offering >90% yield and superior purity. Ideal for pharmaceutical manufacturers seeking cost-effective, scalable API intermediates.
Patent CN110106130B details a robust transaminase-PLP co-immobilized cell method for sitagliptin intermediates, offering superior stability and cost efficiency for pharmaceutical supply chains.
Novel patent CN103619867B offers high-yield estetrol intermediate synthesis with significant cost reduction and enhanced supply chain reliability for global pharmaceutical manufacturing partners.
Advanced synthesis of 5-cyano-2-benzo[c]furanone via amide dehydration. A cost-effective, high-yield route for Citalopram intermediates ensuring supply chain stability.
Advanced synthesis of astemizole key intermediates using fluorescent organoboron catalysts. Delivers high purity, metal-free processes, and scalable supply chain solutions.
Discover the advanced semi-synthesis of Taxol from 10-DAB via selective acetylation. A cost-effective, scalable route for high-purity pharmaceutical intermediates.
Patent CN111995607A details a novel aqueous synthesis for phenyl selenized luteolin and quercetin, offering scalable antiviral intermediate production with reduced costs.
Patent CN101973829A reveals a mild metal-triggered trifluoromethylation method for heterocycles, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Discover the novel Grignard-based synthesis of Nitalapram intermediates avoiding toxic cuprous cyanide. A cost-effective, scalable solution for pharmaceutical manufacturing.